Abigail Jackson

Our latest manuscript just came out in @ImmunityCP describing over a decade of work in the lab studying HIV evolution and escape from HIV broadly neutralizing antibodies. authors.elsevier.com/a/1mgR9_OR%7Ey…

We’ve updated the EVEREST benchmark to include real-world viral evolution! biorxiv.org/content/10.110… Co-led by @nooryoussef03 and me, along with co-authors @navami_jain, @aarushimehrotr, @AgaRosegirl, @_AMJackson, @deboramarks, and with @CEPIvaccines @FutureHouseSF!

and with this tweet, I have officially completed my first year of graduate school...

I stand in solidarity with MIT graduate workers @MITGradUnion as they negotiate for a fair contract. Graduate students do critical work that keeps universities like MIT running. Every worker deserves the right to negotiate for better wages, benefits and workplace conditions.

BREAKING: White House issues new policy that will require, by 2026, all federally-funded research results to be freely available to public without delay, ending longstanding ability of journals to paywall results for up to 1 year. Coverage coming on @ScienceInsider.

With a heavy heart I announce the loss of the Scripps Morgagni. With over 20 years of faithfully mediocre imaging, it is now at peace after a year-long battle with HT issues. RIP

Studying the serum of patients recovered from COVID-19, @WardLab1 have discovered that antibodies exposed to SARS-CoV-2 can also recognize spike proteins of other coronaviruses, such as the common cold scripps.edu/news-and-event… @ScienceAdvances

How the mRNA vaccines were made. In part, thanks to foundational structural biology discoveries made by Prof. Andrew Ward’s lab. nytimes.com/2022/01/15/hea… @WardLab1 @nytimes

Another exciting collaborative preprint is out! Led by @Sandhyareddy88 we mapped the baseline antigenic landscapes to human beta-coronavirus spikes, based on pre-existing immunity to seasonal CoVs, as a basis for predicting antibody responses to SARS CoV-2 biorxiv.org/content/10.110…

A new @scrippsresearch analysis provides a clearer picture of how mutations in recently emerged #SARSCoV2 variants of concern impact antibodies’ neutralization potency, with implications for developing next-generation vaccines and antibody therapies. fcld.ly/vx16m1e

On the major variants: my colleagues @scrippsresearch just published @ScienceMagazine structural and functional assessment of the mutations (found in B.1.351 and P.1) to help guide broad neutralizing Abs and a pan-coronavirus vaccine science.sciencemag.org/content/early/…